FREAMINE 8.5% Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Freamine 8.5%, and when can generic versions of Freamine 8.5% launch?
Freamine 8.5% is a drug marketed by B Braun and is included in one NDA.
The generic ingredient in FREAMINE 8.5% is amino acids. There are three hundred and fifty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the amino acids profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Freamine 8.5%
A generic version of FREAMINE 8.5% was approved as amino acids by B BRAUN on April 13th, 2012.
Summary for FREAMINE 8.5%
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | FREAMINE 8.5% at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for FREAMINE 8.5%
US Patents and Regulatory Information for FREAMINE 8.5%
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B Braun | FREAMINE 8.5% | amino acids | INJECTABLE;INJECTION | 016822-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |